Lamb Weston (LW) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Jan, 2026Executive summary
First quarter results were generally in line with expectations, with net sales down 1% year-over-year to $1,654 million and net income down 46% to $127 million, amid ongoing soft restaurant traffic and frozen potato demand.
Announced a restructuring plan including permanent closure of the Connell, Washington facility, temporary production curtailments, a 4% global headcount reduction, and a $100 million reduction in FY25 capital expenditures, aiming for $55 million in pre-tax savings in FY25 and $85 million annualized.
Restructuring expected to result in $200–$250 million pre-tax charges, mostly in Q2 FY25, with 20% non-cash and 80% cash components.
Potato crops in North America are slightly above average, while European crops are expected to be in line with historical averages.
Financial highlights
Net sales for Q1 FY25 declined 1% year-over-year to $1,654.1 million; North America sales down 3% to $1,103.7 million, International up 4% to $550.4 million.
Adjusted gross profit dropped $143.5 million to $356 million, mainly due to a $39 million voluntary product withdrawal, higher depreciation, and increased manufacturing costs.
Adjusted EBITDA was $290 million, down $123 million from the prior year, primarily due to higher costs and the product withdrawal.
Net income dropped $107.4 million to $127.4 million; diluted EPS was $0.88, down from $1.60 year-over-year.
Gross margin was 21.5%, about 100-150 basis points below target and down from 30% year-over-year, mainly due to the product withdrawal.
Outlook and guidance
Fiscal 2025 net sales targeted at $6.6–$6.8 billion (2–5% growth), with volume as the main driver.
Adjusted EBITDA expected at the low end of $1.38–$1.48 billion due to higher manufacturing costs and less favorable mix.
Adjusted diluted EPS target reduced to $4.15–$4.35; GAAP diluted EPS target lowered to $2.70–$3.15.
Adjusted SG&A target lowered to $680–$690 million; interest expense and tax rate estimates increased.
Capital expenditures for FY25 reduced by $100 million to $750 million.
Latest events from Lamb Weston
- Q3 FY25 sales up 4% with higher volume, cost savings, and reaffirmed guidance amid headwinds.LW
Q3 20254 Feb 2026 - Q4 sales rose 4% with cost savings; 2026 outlook focuses on efficiency and cash flow.LW
Q4 20254 Feb 2026 - Q4 profit plunged on soft demand, share losses, and product withdrawal; FY25 outlook cautious.LW
Q4 20243 Feb 2026 - Q2 FY25 results missed expectations, with lower sales, a net loss, and reduced full-year guidance.LW
Q2 202510 Jan 2026 - Q2 2026 saw 8% volume growth, margin headwinds, and a 3% dividend increase.LW
Q2 202619 Dec 2025 - Board refresh, CEO transition, and pay-for-performance drive strategic and governance changes.LW
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, highlighting governance, pay, and ESG focus.LW
Proxy Filing1 Dec 2025 - Proxy covers director elections, say-on-pay, auditor ratification, and officer exculpation amendment.LW
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, auditor ratification, and officer exculpation.LW
Proxy Filing1 Dec 2025